Wockhardt Investor Relations Material
Latest events
Q4 24/25
29 May, 2025
Q3 24/25
7 Feb, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Wockhardt Limited
Access all reports
Wockhardt Limited is a pharmaceutical and biotechnology company engaged in the research, development, manufacturing, and marketing of pharmaceutical formulations, biopharmaceuticals, and active pharmaceutical ingredients (APIs). The company operates across therapeutic areas including anti-infectives, cardiology, neurology, and diabetes care. It has manufacturing and research facilities that comply with international regulatory standards and serves both domestic and global markets. The company is headquartered in Mumbai, India, and its shares are listed on the BSE.
Latest articles
)
Eli Lilly: The Pharma Giant Behind Mounjaro and Zepbound
Eli Lilly's journey from insulin pioneer to global pharma giant, leading innovation in diabetes, obesity, and the future of metabolic health.
30 Jun 2025
)
500 Years of Craft, One Family Legacy: Beretta Holding's Global Expansion
How Beretta Holding managed to transform from a 16th-century gun barrel producer into a global industrial group while preserving 500 years of legacy.
27 Jun 2025
)
Shuntaro Furukawa: The Sixth President of Nintendo
Shuntaro Furukawa, Nintendo's sixth president, went from a childhood fan to leading the company through global expansion and the launch of Switch 2.
23 Jun 2025
Ticker symbol
WOCKPHARMA
Country
🇮🇳 India